Medicaid

McKesson’s Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services

IRVING, Texas--(BUSINESS WIRE)--For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS)…

5 months ago

McKesson’s Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services

IRVING, Texas--(BUSINESS WIRE)--For the eighth consecutive year, McKesson has received approval from the Centers for Medicare & Medicaid Services (CMS)…

5 months ago

BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA

SUNNYVALE, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (“BioCardia” or the “Company”) (Nasdaq: BCDA), a biotechnology company focused on…

5 months ago

Therma Bright’s Venowave Accepted for Review By Center for Medicare & Medicaid Services for Permanent CPT and HCPCS codes

Company To Resume Trading on Toronto Stock Exchange Venture (TSXV) on February 7, 2024Toronto, Ontario--(Newsfile Corp. - February 6, 2024)…

5 months ago

Manifest MedEx Launches the California ADT Network, a Free Acute and Post-Acute Event Notification Exchange for California

The statewide nonprofit health information organization will send and receive Admit, Discharge, and Transfer (ADT) notifications at no cost for…

6 months ago

Manifest MedEx Launches the California ADT Network, a Free Acute and Post-Acute Event Notification Exchange for California

The statewide nonprofit health information organization will send and receive Admit, Discharge, and Transfer (ADT) notifications at no cost for…

6 months ago

HCA Healthcare Reports Fourth Quarter 2023 Results and Provides 2024 Guidance

Bill Rutherford to Retire and Mike Marks to Become CFONASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and…

6 months ago

Verrica Pharmaceuticals Receives Permanent J-Code (J7354) for YCANTH™ from Centers for Medicare and Medicaid Services

WEST CHESTER, Pa., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology…

6 months ago

CVRx Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

MINNEAPOLIS, Jan. 25, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and…

6 months ago